Stryker, Zimmer Biomet, SeaSpine & more: 24 device company key notes

Anuja Vaidya -   Print  |

Here are 24 key notes on orthopedic and spine device companies from the past week.

U.S. District Judge Robert Jonker in Grand Rapids, Mich., found in favor of Stryker Corp., in a patent infringement case against Zimmer Biomet and awarded the orthopedic device company giant $248.7 million.


Zimmer Biomet's second quarter revenue hit $1.9 billion, a 1.1 percent increase over the same period in 2016.


David Dvorak stepped down as Zimmer Biomet CEO and the company is conducting a search for his replacement.


The U.S. Federal Trade Commission granted Jana Partners clearance to purchase Zimmer Biomet shares. The decision allows the hedge fund to purchase additional stake in the company.


The Medicrea Group reported sales totaling $16.75 million for the first half of the year.


SeaSpine predicts revenue to hit between $34 million and $34.2 million for the second quarter of 2017, reflecting a 3 percent increase over the same period the year prior.


SeaSpine reported the limited commercial launch of its Skipjack Expandable Interbody System.


CTL Medical signed a partnership agreement with G-21 to market G-21's bone cement, kyphoplasty and vertebroplasty technology.


Pinnacle Spine Group received a new patent for in situ graft delivery to a fusion device.


InVivo Therapeutics added the first INSPIRE study clinical site in the United Kingdom.


Two studies tested the Providence Medical Technology's DTRAX Expandable Cage system and showed positive results.


Aurora Spine received a loan from a company insider with the aggregate principal amount of $350,000.


Medacta's USA Spine Division almost doubled its revenues over the first quarter of 2016.


Investing News Network identified the top five performing medical device stocks on NASDAQ from the beginning of the year to July 12, and SeaSpine landed among the top five performing medical devices stocks.


Stryker's spine division was named a finalist for the Back Pain Centers of America's 2017 Awards of Excellence in the Technology Innovation Award category.


Spinal Elements named Jason Blain president and COO.


Vertiflex named Michael Enxing the company's new vice president and COO.


InVivo Therapeutics named Richard Toselli, MD, its CMO on July 5.


K2M signed a long term exclusive distribution agreement with Japan Medicalnext for the distribution of K2M's spinal technologies.


Premia Spine initiated the full market release of its Nexux System in Germany.


Richmond, Va.-based Bon Secours St. Francis Medical Center is among the first regional hospitals to leverage Stryker's Mako System.


DePuy Synthes launched its Distal Radius Sterile Kit, a pre-sterilized, single-use kit of instruments and implants to treat wrist fractures.


Tyber Medical received FDA clearance for its TyFix, an all-in-one extremity joint fixation system.


Olympic sprinter James Ellington partnered with Invibio Biomaterial Solutions and CarboFix Orthopedics to support patients recovering from traumatic injuries.


More articles on devices:
Tyber Medical receives FDA clearance: 5 insights
Vertiflex names new vice president, COO: 5 key notes
CTL Medical Corporation partners with G-21: 3 takeaways

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers